The use of aryl-cyclohexylamine derivatives against cns...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/335 (2006.01) A61K 9/20 (2006.01) A61K 9/48 (2006.01) A61K 31/13 (2006.01) A61K 31/137 (2006.01) A61K 31/138 (2006.01) A61K 31/18 (2006.01) A61K 31/357 (2006.01) A61K 31/445 (2006.01) A61K 31/451 (2006.01)

Patent

CA 2280455

The present invention relates to the use of compounds of the general formula (see above formula) wherein Ar1 is phenyl, naphthyl or tetrahydronaphthyl, optionally substituted by hydroxy, lower alkoxy, nitro, amino or methanesulfonamide; Ar2 is phenyl, naphthyl or tetrahydronaphthyl, optionally substituted by lower alkyl or halogen; X is C, CH, C(OH) or N; Y is -CH2-, CH or O Z -CH2-, -CH(CH3)- or -C(CH3)2-; R1 is hydrogen, lower alkyl or acetyl; A its C=O or -(CHR2)n-, wherein R2 is hydrogen, lower alkyl or hydroxy-lower alkyl; B is -(CH2)n-, O, -CH(OH)(CH2)n-, -CH(CH2OH)(CH2)n-, -(CH2)nCH(OH)- or -CH(CH2OH)-; --- may be a bond and n is 0-4 and to pharmaceutically acceptable acid addition salts thereof for the manufacture of medicaments which represent therapeutic indications for NMDA receptor subtype specific blockers.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

The use of aryl-cyclohexylamine derivatives against cns... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with The use of aryl-cyclohexylamine derivatives against cns..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and The use of aryl-cyclohexylamine derivatives against cns... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1782208

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.